| Stage | BX | % of rev | GCMG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.0B | 100.00% | $134M | 100.00% | BX ×37.55 |
| Gross profit | $5.0B | 100.00% | $63M | 47.02% | BX +53.0pp |
| Operating income | $2.7B | 52.90% | $35M | 26.41% | BX +26.5pp |
| Pre-tax income | $2.8B | 55.68% | $36M | 26.46% | BX +29.2pp |
| Net income | $2.4B | 46.71% | $32M | 23.71% | BX +23.0pp |
| Stage | BX | GCMG | Gap · A − B |
|---|---|---|---|
| Revenue | $5.0B100.00% | $134M100.00% | BX ×37.55 |
| Gross profit | 100.00%$5.0B | 47.02%$63M | BX +53.0pp |
| Operating income | 52.90%$2.7B | 26.41%$35M | BX +26.5pp |
| Pre-tax income | 55.68%$2.8B | 26.46%$36M | BX +29.2pp |
| Net income |
| 46.71%$2.4B |
| 23.71%$32M |
| BX +23.0pp |
No disclosed counterparties: GCMG.
None